| | | | | 经鼻黏膜诱导免疫耐受治疗实验性自身免疫性葡萄膜炎 | | | 郑曰忠;原莉莉;林锦镛;李会强 | | | 目的探讨经鼻腔滴注牛视网膜S抗原诱导免疫耐受对Lewis大鼠自身免疫性葡萄膜视网膜炎(EAU)的影响。方法利用盐析和离子交换层析方法纯化牛视网膜S抗原,然后用其诱导Lewis大鼠鼻黏膜耐受,再用视网膜S抗原诱发EAU,观察EAU的发病情况、眼部临床表现、组织学改变、皮肤迟发型超敏反应、由视网膜S抗原和刀豆蛋白A刺激的淋巴细胞增殖反应,同时观察环磷酰胺对免疫耐受的影响。结果用牛视网膜S抗原鼻腔滴注诱导免疫耐受后再诱导EAU,耐受组8只大鼠仅有2只发病(25%),对照组6只(100%)全部发病,耐受组大鼠发病比例明显低于对照组(P=0·0097)。耐受组大鼠的发病开始时间平均为16·5d,对照组为10·3d,两者之间差异有统计学意义(F=26·32,P=0·000;q=9·723,P<0·01);耐受组大鼠EAU病变的临床评分为0·89,对照组为3·94,差异有统计学意义(F=12·48,P=0·000;q=7·904,P<0·01);耐受组大鼠的组织学分级为1·21,对照组为4·12,差异有统计学意义(F=11·80,P=0·000;q=7·510,P<0·01)。耐受组大鼠的EAU表现为虹膜血管轻度扩张,前房和玻璃体内少量炎性渗出,视网膜轻度肿胀,视网膜感光细胞损害均较轻。耐受组大鼠的皮肤迟发型超敏反应和由视网膜S抗原刺激的淋巴细胞增殖反应也明显轻于对照组;腹腔注射环磷酰胺可轻度增强S抗原诱导的免疫耐受作用,仅用环磷酰胺对EAU的炎性反应无明显影响。结论视网膜S抗原诱导的黏膜耐受可有效地预防由视网膜S抗原诱发的EAU。
【作者单位】：天津市眼科医院;天津市眼科医院;天津市眼科医院;天津医科大学免疫学教研室
【关键词】：葡萄膜炎;自身免疫疾病;免疫耐受;自身抗原
【基金】：天津市自然科学基金资助项目(01361021
【分类号】：R773.4
【DOI】：CNKI:ISSN:0412-4081.0.2006-12-025
【正文快照】：
葡萄膜炎是一类主要累及儿童和青壮年人的致盲性眼病,在美国约占致盲患者的10%,在我国其患病率和危害程度也日趋严重[1]。确切发病机制不清,研究表明多与机体免疫功能异常或自身免疫反应有关[2]。局部和(或)全身应用糖皮质激素是主要治疗方法,严重者还需加用免疫抑制剂,这两类药物的毒副反应很大。近年来研究发现应用自身抗原诱导机体免疫耐受能抑制一些实验性自身免疫性疾病,取得了较好效果[2-5]。为进一步了解诱导耐受对实验性自身免疫性葡萄膜炎(experimentalautoimmune uveoretinitis,EAU)的治疗作用,我们通过鼻黏膜给予视网膜S抗原诱… | | |  推荐 CAJ下载  PDF下载 | | | CAJViewer7.0阅读器支持所有CNKI文件格式，AdobeReader仅支持PDF格式 | | | | The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction | | | ZHENG Yue-zhong;YUAN Li-li;LIN Jin-yong;LI Hui-qiang. Tianjin Eye Hospital;Tianjin 300020;China | | | Objective The aim was to investigate the suppression of rat experimental autoimmune uveoretinitis(EAU) by induced immune tolerance via intranasal administration of retinal S antigens. Methods The bovine S antigen was purified from bovine retina by salt precipitation and ionic exchange chromatography, the female Lewis rats were used to induce immune tolerance by intranasal administration with purified bovine retinal S antigens and then the rats were used to produce the EAU model by retinal S antigens challenge. The rate of EAU occurrence, the clinical and histological scores, the skin delayed-type hypersensitivity and lymphocyte proliferation stimulated by retinal S antigen and concanavalin A were recorded. The adjunct effect of cyclophosphamide on tolerance induction was observed. Results After intranasal administration of retinal S antigens, EAU was induced in two of eight(25%) rats in tolerant group, sis of six(100%) rats in control group , the difference of EAU induction rate was significant in tolerant group compared with control (P=0.0097). The average onset time in tolerant group were 16.5 days, the control group was 10.3 days, the difference was significant (F=26.32,P=0.000; q=9.723, P< 0.01). The average clinical scores of EAU in tolerant group were 0.89, the control group was 3.94, the difference was significant(F=12.48,P=0.000; q=7.904,P<0.01). The average histological scores of EAU in tolerant group were 1.21, the control group was 4.12, the difference was significant(F=11.80, P= 0.000; q=7.510,P<0.01). The histological features in tolerant group were iris blood vessels slightly dilation, few exudates in anterior chamber and vitreous cavity; there were slighter retina swallow and the photoreceptors damages in the tolerant group. The skin delayed-type hypersensitivity and the proliferative responses of lymphocytes stimulated by S antigen and concanavalin A in tolerant group were slighter than that in the control group. Intraperitoneal injection of cyclophosphamide enhanced the effect of immune tolerance slightly. Only intraperitoneal injection of cyclophosphamide did not diminish the severity of the rat EAU. Conclusion The intranasal induced tolerance by retinal S antigens can suppress effectively the prevalence of rat experimental autoimmune uveoretinitis induced by retinal S antigens.
【Keyword】：Uveitis;Autoimmune diseases;Immune tolerance;Autoantigens |
| | | | | | 1 | 朱平!710032西安,王彦宏!710032西安,冷南!710032西安,王树宽!710032西安,吴振彪!710032西安,解慧!710032西安,张惠琴!710032西安,樊春梅!710032西安; 口服Ⅱ型胶原诱导免疫耐受对佐剂性关节炎免疫病理和Th亚群的作用 [J];中华风湿病学杂志; 2000年05期 | | 2 | 王维治!150086,王丽宏!150086,杨秋霞!150086,杨春娥!150086; 实验性自身免疫性脑脊髓炎豚鼠鼻粘膜免疫耐受研究 [J];中华神经科杂志; 1999年06期 |
|
| | | | | | 1 | Batten P, McCormack AM, Page CS, et al; Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro [M];Transplantation; 1999年 | | 2 | Kilmartin DJ, Fletcher ZJ, Almeida JA, et al; CD69 expresion on peripheral CD4+ T cell parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis [M];Invest Ophthalmol Vis Sci; 2001年 | | 3 | Xu X, Williams JW, Shen J, et al; In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium [M];J Immunol; 1998年 | | 4 | Varga G, Dreikhausen U, Kracht M, et al; Molecular mechanisms of T lymphocyte activation: convergence of T cell antigen receptor and IL-1 receptor-induced signaling at the level of IL-2 gene transcription [M];Int Immunol; 1999年 | | 5 | Nussenblatt RB, Fortin E, Schiffman R, et al; Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb:a phase I/II clinical trial [M];Proc Natl Acad Sci USA; 1999年 | | 6 | Matsui T, Kurokawa M, Kobata T, et al; Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases [M];J Immunol; 1999年 | | 7 | Sambasivarao D, Hooton J, Dost A, et al; A novel immunosuppressive factor in bovine colostrum blocks activation of the interleukin 2 gene enhancer at the NFAT site [M];Biochem Cell Biol; 1996年 | | 8 | Thurau SR, Diedrichs-mohring M, Fricke H, et al; Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis [M];Immunol Lett; 1999年 | | 9 | Hara Y, Caspi RR, Wiggert B, et al; Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis [M];Curr Eye Res; 1992年 | | 10 | Zhang M, Zhao X, Li H, et al; Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein [M];Chin Med Sci J; 1995年 |
|
| | | | | | 1 | Heinz C.,Plentz A.,Bauer D. ,王文军; 内源性葡萄膜炎患者体内病毒B19DNA及细小病毒B19特异性抗体的患病率 [J];世界核心医学期刊文摘(眼科学分册); 2006年04期; 52-53 | | 2 | 杨培增; 我国葡萄膜炎的诊治水平亟待提高 [J];中华眼科杂志; 2002年04期; 4-6 | | 3 | 杨培增，李绍珍; 葡萄膜炎的研究现状及展望 [J];中华眼底病杂志; 1994年03期; 130-132 | | 4 | 杨培增,周红颜; 葡萄膜炎基础研究的新进展——第四届国际葡萄膜炎大会纪要 [J];国外医学.眼科学分册; 1998年04期; 1-4 | | 5 | 卢弘，张茶芝，姚仁祥; 130例葡萄膜炎的临床分析 [J];中华眼底病杂志; 1994年03期; 156-158 | | 6 | Lim W.-K.,Ursea R.,R.B. Nussenblatt,韩静; 自身免疫性淋巴组织增生综合征患者的双侧葡萄膜炎 [J];世界核心医学期刊文摘.眼科学分册; 2005年08期; 35 | | 7 | Chi-Chao Chan; 葡萄膜炎的免疫病理学 [J];眼科学报; 1985年02期; 39-41 | | 8 | 宋艳,詹宇坚,古继红; 葡萄膜炎与相关细胞因子的研究进展 [J];中国中医眼科杂志; 2004年03期; 60-62 | | 9 | 杨培增,张震; 葡萄膜炎免疫治疗的进展与展望 [J];中华眼科杂志; 2002年09期; 65-67 | | 10 | 杨培增,俞琼; 准确诊断和合理治疗葡萄膜炎 [J];中华眼科杂志; 2004年08期; 5-6 |
|
| | | | | | 1 | 王召英; 中西医结合治疗葡萄膜炎二例 [A];全国第七届农村基层中西医结合学术暨工作交流会论文汇编集 [C]; 2002年 | | 2 | 葡萄膜炎与免 [A];中华医学会第九届全国眼科学术大会论文汇编 [C]; 2004年 | | 3 | 杨培增; 葡萄膜炎治疗中的思维方式 [A];第三届全球华人眼科学术大会暨中华医学会第十一届全国眼科学术大会论文汇编 [C]; 2006年 | | 4 | 阮克奋; 葡萄膜炎中西医治疗再探讨——复发性葡萄膜炎的治疗 [A];浙江省中西医结合学会眼科专业委员会第八次学术年会暨省级继续教育学习班资料汇编 [C]; 2005年 | | 5 | 汪运山,姜莉华,申红,潘光锦,牟国营,亓同钢,张源潮; HLA-B51与白塞病葡萄膜炎的相关性研究 [A];2004第二届世界华人临床生化和检验医学大会第六届全国检验医学学术会议论文汇编 [C]; 2004年 | | 6 | 舒灿,朱小华,陈雨; 平坦部葡萄膜炎伴复杂性视网膜脱离的手术 [A];第三届全球华人眼科学术大会暨中华医学会第十一届全国眼科学术大会论文汇编 [C]; 2006年 | | 7 | 王红; 玻璃体切除术治疗葡萄膜炎 [A];第三届全球华人眼科学术大会暨中华医学会第十一届全国眼科学术大会论文汇编 [C]; 2006年 | | 8 | 郑曰忠,时冀川; 病毒性角膜葡萄膜炎 [A];第三届全球华人眼科学术大会暨中华医学会第十一届全国眼科学术大会论文汇编 [C]; 2006年 | | 9 | 郑曰忠,时冀川; 葡萄膜炎患者外周血肿瘤坏死因子和白介素-6水平的检测及意义 [A];第三届全球华人眼科学术大会暨中华医学会第十一届全国眼科学术大会论文汇编 [C]; 2006年 | | 10 | 丁丽霞,冯永堂,鞠吉雨,苗乃法,魏兵; OX40在实验性自身免疫性葡萄膜炎中的表达 [A];第6次全国微生物学与免疫学大会论文摘要汇编 [C]; 2004年 |
|
|
|
